Clinical trial
Angiography-derived Index of Microcirculatory Resistance Predicts Microvascular Obstruction and Infarct Size in Patients With ST-segment-elevation Myocardial Infarction
NCT06947564 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Angiography-derived Index of Microcirculatory Resistance Predicts Microvascular Obstruction and Infarct Size in Patients With ST-segment-elevation Myocardial Infarction
- Lead sponsor
- RenJi Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2012
- Completion date
- December 31, 2024
- Enrollment
- 843 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease, microvascular coronary artery disease, stemi - st elevation myocardial infarction